explore -WSS

explore

author：focus 2025-10-03 00:40:52 - browse：79883

the Federal Trade Commission building and its brown sign — Adobe

A federal judge ordered Wednesday that Novant Health can move forward with its plan to buy two North Carolina hospitals, denying the Federal Trade Commission’s request for an injunction.

The FTC sued to block the deal in January, arguing that it would give Novant control of more than 65% of the region’s inpatient market. The case, one seeking to block nearby hospitals from merging and creating an even more powerful dominant player, is the FTC’s bread and butter. The agency has shied away from challenging cross-market and vertical mergers, but this one is right in its wheelhouse, which makes the setback surprising.

Under the deal, announced early last year, Novant would buy two hospitals in the same county from for-profit Community Health Systems for $320 million. The hospitals, Lake Norman Regional Medical Center and Davis Regional Medical Center, are only a 25-minute drive from one another. Davis Regional used to be a full-service hospital, but is now a psychiatric hospital. The deal also includes a group of 24 doctors, a majority interest in an endoscopy center, and a holding in a planned surgery center.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： SCOTUS to consider access to abortion pill mifepristone

knowledge

WSS

Radiology is caught between AI's potential and concern for patients

Congenital heart disease patients face new threat of heart failure

Merck drug for rare lung condition set for approval in U.S.

Roche to buy Carmot Therapeutics, developer of obesity drugs

Will generative AI in health care meet the fate of IBM's Dr. Watson?

Decaf coffee targeted by food safety group under obscure FDA rule

Wikipedia

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

hotspot

What does generative AI mean for health care? We asked experts

Roche subsidiary Foundation Medicine opens new headquarters

Continuity nursing helped my family in our darkest PICU moments

Washington mulls new rules to avert another Change Healthcare

Walensky prepares to leave CDC — and Congress — behind

Pfizer plans to depart BIO

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Supreme Court mifepristone arguments center on docs' right to sue

The high cost of giving birth even with insurance

Abortion pill case raises question: who can sue the FDA?

explore

AI models in health care face new federal disclosure requirements

Roche to buy Carmot Therapeutics, developer of obesity drugs

Abortion pill Supreme Court ruling could impact entire drug industry

Steward Health Care has deal to sell doctor network to UnitedHealth

Congenital heart disease patients face new threat of heart failure

Patient advocates debate FDA's accelerated approval process

knowledge

knowledge

explore

knowledge